Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with our customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards.
Financial Results:
Jubilant Ingrevia Ltd reported Revenues for Q4FY25 of ₹1,051.00 Crores down from ₹1,074.00 Crore year on year, a fall of 2.14%.
Total Expenses for Q4FY25 of ₹958.00 Crores down from ₹1,033.00 Crores year on year, a fall of 7.26%.
Consolidated Net Profit of ₹74.00 Crores up 155.17% from ₹29.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹4.65, up 152.72% from ₹1.84 in the same quarter of the previous year.